COMMUNIQUÉS West-GlobeNewswire

NEOVACS ANNOUNCES THE CLOSING OF A €6.0 MILLION PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONAL INVESTORS
04/08/2017
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE CLOSING OF A €6.0 MILLION PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONAL INVESTORS Paris and Boston, August 4, 2017 - 5:45 pm CET - Neovacs ( [...]
Oriola Corporation - Repurchase of own shares on 4 August 2017
04/08/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 4 August 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 4 August 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 23 230 Average price/share, EUR 3,6907 [...]
Shire plc : Half-yearly report
04/08/2017
Half-yearly Report August 4, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), ("Shire" / the "Group") in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, is publishing its Half- [...]
Curetis to Report its Half-Year Results 2017 on August 16, 2017
04/08/2017
Curetis to Report its Half-Year Results 2017 on August 16, 2017 - Company will host earnings conference call and webcast Amsterdam, the Netherlands, and Holzgerlingen, Germany, August 04, 2017; published at 08:00 am CET [...]
Fagron NV: Higher turnover and profit for Fagron
04/08/2017
Regulated information | Consolidated results for the first half of 2017 Nazareth (Belgium) / Rotterdam (The Netherlands), 4 August 2017 Higher turnover and profit for Fagron Significant decrease of net debt/REBITDA- [...]
VALNEVA : Déclaration d'actions et de droits de vote - JUILLET 2017
03/08/2017
Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché réglementé Euronext Paris de Nyse Euronext - Compartiment B Date de [...]
Oriola Corporation - Repurchase of own shares on 3 August 2017
03/08/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 3 August 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 3 August 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 8 401 Average price/share, EUR 3.6629 [...]
Auris Medical to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 10, 2017
03/08/2017
Zug, Switzerland, August 3, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced [...]
Minerva Neurosciences Reports Second Quarter 2017 Financial Results and Business Updates
03/08/2017
FDA feedback on clinical trial design and completion of bridging study with new formulation enable initiation of Phase 3 trial with MIN-101 to treat negative symptoms of schizophrenia in second half of 2017 Amended [...]
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
03/08/2017
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PRESENT AT THE CANACCORD GENUITY GROWTH CONFERENCE Oxford, UK, 3 August 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Shire plc : Shire reports strong Q2 2017 operating results and cash flow
03/08/2017
Shire reports strong Q2 2017 operating results and cash flow; updates full year guidance Q2 product sales growth of 7% on a combined pro forma basis; generated $1.2 billion operating cash flow Over-delivered Year 1 [...]
Changes in Nexstim Plc's Management Team
03/08/2017
Company announcement, Helsinki, 3 August 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]
Idorsia announces half year results for 2017 - successful start of new biopharmaceutical company
03/08/2017
Financial Statements Half Year 2017 Press release PDF Financial Fact Sheet This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this [...]
Apricus Biosciences Provides Corporate Update and Second Quarter 2017 Financial Results
02/08/2017
Vitaros Drug-Device Human Factor Studies Successfully Completed Vitaros U.S. NDA Final Draft Completed with Re-Submission Expected in Current Quarter Conference Call / Webcast Today, August 2, 2017 at 4:30 p.m. ET SAN [...]
Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2017
02/08/2017
EASTPHARMA LTD. London, 02 August 2017 - EastPharma (EAST LI) informs that it will be releasing its reviewed financial statements for the period 30 June 2017 and a review of its main subsidiary DEVA Holding's financial [...]
Oriola Corporation - Repurchase of own shares on 2 August 2017
02/08/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 2 August 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 2 August 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 6440 Average price/share, EUR 3,63 Total [...]
Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development Update
02/08/2017
LONDON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus(TM) Surgical Aortic Valve
02/08/2017
Introduction of New Pericardial Aortic Heart Valve in the U.S. and Europe Reinforces Company's Commitment to Comprehensive Solutions to Heart Valve Disease DUBLIN - August 2, 2017 - Medtronic plc (NYSE: MDT) today [...]
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
02/08/2017
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia Randomized, double-blind, placebo-controlled study to enroll up to 500 patients [...]

Pages